99 related articles for article (PubMed ID: 6155727)
1. 13,14-Dihydro-15-keto-prostaglandin F2 alpha in patients with urogenital tumors.
Dunzendorfer U; Zahradnik HP; Gerster K
Urol Int; 1980; 35(3):171-5. PubMed ID: 6155727
[TBL] [Abstract][Full Text] [Related]
2. [13,14-Dihydro-15-keto prostaglandin F2 alpha and haptoglobin in the serum of patients with urogenital tumors].
Dunzendorfer U; Ohlenschläger G; Zahradnik HP
Onkologie; 1981 Feb; 4(1):10-6. PubMed ID: 6164028
[TBL] [Abstract][Full Text] [Related]
3. Transferrin, C3 complement, haptoglobin, plasminogen and alpha 2-microglobulin in patients with urogenital tumors.
Dunzendorfer U; Jung K; Ohlenschläger G
Eur Urol; 1980; 6(4):232-6. PubMed ID: 6156074
[TBL] [Abstract][Full Text] [Related]
4. Evidence against the formation of 13,14-dihydro-15-keto-prostaglandin F2 alpha following inhalation of prostaglandin D2 in man.
Hardy CC; Holgate ST; Robinson C
Br J Pharmacol; 1986 Mar; 87(3):563-8. PubMed ID: 3467804
[TBL] [Abstract][Full Text] [Related]
5. Half-life of 13,14-dihydro-15-keto prostaglandin f2 alpha in peripheral plasma of the pig.
Martin KA; Liptrap RM
Res Vet Sci; 1981 Nov; 31(3):387-9. PubMed ID: 7342231
[TBL] [Abstract][Full Text] [Related]
6. Measurement of 13,14-dihydro-15-keto-prostaglandin F2 alpha and 6-keto-prostaglandin F1 alpha in plasma by radioimmunoassay without prior extraction or chromatography.
Strickland DM; Brennecke SP; Mitchell MD
Prostaglandins Leukot Med; 1982 Nov; 9(5):491-3. PubMed ID: 6960375
[No Abstract] [Full Text] [Related]
7. [Indicators of alkaline phosphatase and peroxidase in the leukocytes of the peripheral blood in patients with cancer of the urogenital system].
Matskiv AS; Zabolotskiĭ AT; Sultan NN
Vrach Delo; 1973 Nov; 11():67-70. PubMed ID: 4132245
[No Abstract] [Full Text] [Related]
8. Prolactin, LH, TSH, T3 and T4 in patients with urogenital carcinomas.
Dunzendorfer U; Knöner M; Drahowsky D
Urol Int; 1979; 34(3):190-8. PubMed ID: 573007
[TBL] [Abstract][Full Text] [Related]
9. Prostacyclin, thromboxane and prostaglandin F2 alpha; plasma levels in breast cancer.
Vergote I; Laekeman G; Heiremans J; Becquart D; Buytaert P; Herman A
Tumour Biol; 1986; 7(5-6):407-10. PubMed ID: 3554471
[TBL] [Abstract][Full Text] [Related]
10. Serum finding associated with carcinoma of kidney.
Wise GJ; Ostad A
Urology; 1973 Oct; 2(4):418-20. PubMed ID: 4127702
[No Abstract] [Full Text] [Related]
11. Changes in plasma oxytocin, prostaglandin E1, and 13,14-dihydro-15-keto-prostaglandin F2 alpha during labor induced by prostaglandin E2 or F2 alpha and spontaneous labor.
Nagata I; Seki K; Uesato T; Sunaga H; Furuya K; Makimura N; Kato K
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Sep; 39(9):1627-33. PubMed ID: 3479503
[TBL] [Abstract][Full Text] [Related]
12. Perioperative behavior of prostaglandin E2 and 13,14-dihydro-15-keto-PGF2 alpha in serum of bronchial carcinoma patients.
Fiedler L; Zahradnik HP; Schlegel G
Adv Prostaglandin Thromboxane Res; 1980; 6():585-6. PubMed ID: 7386293
[No Abstract] [Full Text] [Related]
13. Plasma levels of 13,14-dihydro-15-keto prostaglandin F2 alpha in relation to oviposition and ovulation in the domestic hen (Gallus domesticus).
Olson DM; Hertelendy F
Biol Reprod; 1981 Apr; 24(3):496-504. PubMed ID: 6165407
[No Abstract] [Full Text] [Related]
14. Suppression of plasma 6-keto-prostaglandin F1 alpha and 13,14-dihydro-15-keto-prostaglandin F2 alpha by aminoglutethimide in advanced breast cancer.
Harris AL; Mitchell MD; Smith IE; Powles TJ
Br J Cancer; 1983 Oct; 48(4):595-8. PubMed ID: 6688732
[No Abstract] [Full Text] [Related]
15. Oxytocin and initiation of human parturition. III. Plasma concentrations of oxytocin and 13,14-dihydro-15-keto-prostaglandin F2 alpha in spontaneous and oxytocin-induced labor at term.
Fuchs AR; Goeschen K; Husslein P; Rasmussen AB; Fuchs F
Am J Obstet Gynecol; 1983 Nov; 147(5):497-502. PubMed ID: 6638091
[TBL] [Abstract][Full Text] [Related]
16. [Perioperative behavior of prostaglandin E2 (PGE2) and 13,14-dihydro-15-keto-PGF2 alpha (DHK-PGF2 alpha) in the serum in bronchial cancer].
Fiedler L; Schlegel G; Kaiser D; Zahradnik HP
Onkologie; 1979 Jun; 2(3):108-12. PubMed ID: 392376
[TBL] [Abstract][Full Text] [Related]
17. Delayed luteolysis and suppression of the pulsatile release of oxytocin after indomethacin treatment in the goat.
Cooke RG; Homeida AM
Res Vet Sci; 1984 Jan; 36(1):48-51. PubMed ID: 6538694
[TBL] [Abstract][Full Text] [Related]
18. Estimation of 13, 14-dihydro-15-keto-prostaglandin F2 alpha (PGF2 alpha M) in patients with endometriosis.
Wang YF; Han ML; Sun AD; Huang RL; Zhang H; Ma XH; Cheng JX; Duan JH
Proc Chin Acad Med Sci Peking Union Med Coll; 1987; 2(2):107-10. PubMed ID: 3423006
[No Abstract] [Full Text] [Related]
19. Plasma prostaglandin levels in radiation-induced enteritis.
Lifshitz S; Savage JE; Taylor KA; Tewfik HH; Van Orden DE
Int J Radiat Oncol Biol Phys; 1982 Feb; 8(2):275-7. PubMed ID: 7085382
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunoassay of the major plasma metabolite of PGF2 alpha, 15-keto-13,14-dihydro-PGF2 alpha.
Granström E; Kindahl H
Methods Enzymol; 1982; 86():320-39. PubMed ID: 6957702
[No Abstract] [Full Text] [Related]
[Next] [New Search]
